The first AACR virtual meeting of 2021, held Jan. 11-12, focused on the tumor microenvironment, the complex framework of immune cells, blood vessels, fibroblasts, and other cell types that surround a tumor and can...
An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and more news of the week from Cancer Today.
Trial results raise questions about two immune checkpoint inhibitors approved for treatment of some people with advanced breast cancer.
Fecal transplants may improve immunotherapy responses, and more news of the week from Cancer Today.
Increasing representation in the biomedical workforce would have many benefits, including reducing implicit biases and cultural incompetency in the treatment of minority patients with cancer, as well as ensuring the inclusion of diverse perspectives and enhancing innovation and creativity in cancer research.
Advocates are asking that cancer patients be prioritized for COVID-19 vaccination, and more news of the week from Cancer Today.
African American men are more likely to feel regret about prostate cancer treatment decisions, and more news of the week from Cancer Today.
People are using crowdsourced fundraising to cover cancer care costs, and more news of the week from Cancer Today.
Researchers in Japan observe the rare occurrence of a mother passing cancer cells to their child, and more news of the week from Cancer Today.
In the early 1970s, German virologist Harald zur Hausen, MD, FAACR, defied the dogma that cervical cancer was caused by the herpes simplex virus (HSV). He proposed that another virus—the human papillomavirus (HPV)—could lead to cervical cancer. While his initial studies...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More